These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 3609395)

  • 1. [Pathological characteristics of the thyroid gland in patients with triiodothyronine-predominant Graves' disease].
    Miki K; Takamatsu J; Sakane S; Majima M; Kitaoka H; Kitazawa A; Mozai T; Katayama S; Morita S; Kobayashi A
    Nihon Naibunpi Gakkai Zasshi; 1987 Mar; 63(3):184-92. PubMed ID: 3609395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epithelial hyperplasia and decreased colloid content of the thyroid gland in triiodothyronine-predominant Graves' disease.
    Takamatsu J; Takeda K; Katayama S; Sakane S; Morita S; Kuma K; Ohsawa N
    J Clin Endocrinol Metab; 1992 Oct; 75(4):1145-50. PubMed ID: 1400885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced thyroid iodine metabolism in patients with triiodothyronine-predominant Graves' disease.
    Takamatsu J; Hosoya T; Naito N; Yoshimura H; Kohno Y; Tarutani O; Kuma K; Sakane S; Takeda K; Mozai T
    J Clin Endocrinol Metab; 1988 Jan; 66(1):147-52. PubMed ID: 3335601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ratio of serum triiodothyronine to thyroxine and the prognosis of triiodothyronine-predominant Graves' disease.
    Takamatsu J; Sugawara M; Kuma K; Kobayashi A; Matsuzuka F; Mozai T; Hershman JM
    Ann Intern Med; 1984 Mar; 100(3):372-5. PubMed ID: 6546484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thyroidal triiodothyronine and thyroxine in Graves' disease: correlation with presurgical treatment, thyroid status, and iodine content.
    Larsen PR
    J Clin Endocrinol Metab; 1975 Dec; 41(06):1098-104. PubMed ID: 54364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genes that characterize T3-predominant Graves' thyroid tissues.
    Matsumoto C; Ito M; Yamada H; Yamakawa N; Yoshida H; Date A; Watanabe M; Hidaka Y; Iwatani Y; Miyauchi A; Takano T
    Eur J Endocrinol; 2013 Feb; 168(2):137-44. PubMed ID: 23109646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Persistently increased gastrin and decreased pepsinogen concentrations in serum from some patients with Graves' disease of triiodothyronine-predominant type and common type.
    Fukao A; Takamatsu J; Shimamoto C; Kuma K; Ohsawa N
    Thyroid; 1998 Mar; 8(3):259-63. PubMed ID: 9545113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum ratio of triiodothyronine to thyroxine, and thyroxine-binding globulin and calcitonin concentrations in Graves' disease and destruction-induced thyrotoxicosis.
    Amino N; Yabu Y; Miki T; Morimoto S; Kumahara Y; Mori H; Iwatani Y; Nishi K; Nakatani K; Miyai K
    J Clin Endocrinol Metab; 1981 Jul; 53(1):113-6. PubMed ID: 6165731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and pathological significance of sibling Graves' disease.
    Tanaka T; Katayama S; Kuma K; Tamai H; Matsuzuka F; Hidaka H
    Acta Endocrinol (Copenh); 1980 Aug; 94(4):498-502. PubMed ID: 6893640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation of sequential changes in serum thyroglobulin, triiodothyronine, and thyroxine in patients with Graves' disease and subacute thyroiditis.
    Izumi M; Larsen PR
    Metabolism; 1978 Apr; 27(4):449-60. PubMed ID: 580305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of thyrotropin-releasing hormone on serum thyroid hormones: a study in the patients with untreated and treated Graves' disease and subacute thyroiditis.
    Sato A; Yamada T; Aizawa T; Ichikawa K; Komiya I; Takasu N; Takemura Y
    J Clin Endocrinol Metab; 1995 Jul; 80(7):2173-7. PubMed ID: 7608274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fetal goiter identified in a pregnant woman with triiodothyronine-predominant graves' disease: a case report.
    Fujishima A; Sato A; Miura H; Shimoda Y; Kameyama S; Ariake C; Adachi H; Fukuoka Y; Terada Y
    BMC Pregnancy Childbirth; 2020 Jun; 20(1):344. PubMed ID: 32493403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Syndrome of persisting thyroid stimulating immunoglobulins and growth promotion of goiter combined with low thyroxine and high triiodothyronine serum levels in drug treated Graves' disease.
    Wenzel KW; Lente JR
    J Endocrinol Invest; 1983 Oct; 6(5):389-94. PubMed ID: 6141202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Continued suppression of serum TSH level may be attributed to TSH receptor antibody activity as well as the severity of thyrotoxicosis and the time to recovery of thyroid hormone in treated euthyroid Graves' patients.
    Chung YJ; Lee BW; Kim JY; Jung JH; Min YK; Lee MS; Lee MK; Kim KW; Chung JH
    Thyroid; 2006 Dec; 16(12):1251-7. PubMed ID: 17199435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Triiodothyronine generation from thyroxine in human thyroid: enhanced conversion in Graves' thyroid tissue.
    Ishii H; Inada M; Tanaka K; Mashio Y; Naito K; Nishikawa M; Imura H
    J Clin Endocrinol Metab; 1981 Jun; 52(6):1211-7. PubMed ID: 6894450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Total serum thyroxine and triiodothyronine; a comparison between Graves' disease and hyperthyroxinaemia due to thyroxine replacement.
    Pearce CJ; Himsworth RL
    Acta Endocrinol (Copenh); 1984 Oct; 107(2):213-7. PubMed ID: 6548596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum immunoglobulin G4 levels and Graves' disease phenotype.
    Martin CS; Sirbu AE; Betivoiu MA; Florea S; Barbu CG; Fica SV
    Endocrine; 2017 Feb; 55(2):478-484. PubMed ID: 27819113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum triiodothyronine to thyroxine ratio: a newly recognized predictor of the outcome of hyperthyroidism due to Graves' disease.
    Takamatsu J; Kuma K; Mozai T
    J Clin Endocrinol Metab; 1986 May; 62(5):980-3. PubMed ID: 3754263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased production of B-cell growth factor by T lymphocytes in Graves' thyroid: possible role of CD4+ CD29+ cells.
    Goto Y; Itoh M; Ohta Y; Ogawa N; Goto Y; Ohashi H
    Thyroid; 1997 Aug; 7(4):567-73. PubMed ID: 9292944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thyroid function and histology in forty-five patients with hyperthyroid Graves' disease in clinical remission more than ten years after thionamide drug treatment.
    Hirota Y; Tamai H; Hayashi Y; Matsubayashi S; Matsuzuka F; Kuma K; Kumagai LF; Nagataki S
    J Clin Endocrinol Metab; 1986 Jan; 62(1):165-9. PubMed ID: 2415549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.